Navigation Links
Microbial Discovery Group (MDG) in Franklin, WI Completes Expansion
Date:8/8/2014

Franklin, WI (PRWEB) August 08, 2014

Microbial Discovery Group (MDG) LLC celebrated the expansion of their R&D and production facility with a ribbon cutting on August 5th.

Microbial Discovery Group (MDG), founded in 2007 in their current location in Franklin, WI, needed to expand to meet demand for new opportunities for microbial-based products and solutions. MDG added a second laboratory and expanded the MDG facilities and workspaces to double the number of possible employees and accelerate the rate of technology development. This expansion was on the heels of manufacturing expansion and processing changes that almost doubled capacity the year before.

According to MDG founder, Michael King, Ph.D., “As MDG continues to scale-up to meet demand, the number of team members has grown from 2 to 20 employees making this expansion an absolute necessity. We needed to make room for the second laboratory but most importantly needed to house our most valuable asset, our people”. MDG’s talented team includes scientists, engineers, technical support, production, business development and customer support. The $500,000 expansion and facility update added an additional 3500 sq ft of laboratory and office space to house 32 employees.

MDG recently hired 2 scientists and 1 admin position and is currently recruiting two more scientists, a production manager and a regulatory/international registration specialist. MDG will likely add 40% more total staff including more sales positions over the next couple of years. The second laboratory, new equipment and additional staff allows MDG to increase their high throughput microbiology and molecular biology discovery initiatives while providing much needed support infrastructure. This will continue MDG’s strong innovation capabilities but at a much faster rate covering more market segments.

Microbial Discovery Group excels at isolation of novel microbial strains that solve environmental concerns, as well as large-scale manufacturing of environmentally-safe microbials for commercial applications. MDG’s custom fermentation services and products support plant health, aquaculture, animal nutrition, bioremediation, wastewater management, and more. For additional information, please visit: MDGbio.com

Real Science. Trusted Process. Proven Success.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12076377.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Microbial Identification Market worth $1,194.1 Million by 2019
2. Pullman Regional Hospital changes more than 1,100 touch points to Hussey Coppers MD-Cu29 antimicrobial copper to help protect against bacteria
3. MO BIO Laboratories, Inc. launches a new kit for rapid release of microbial DNA from swabs for PCR analysis
4. New Antimicrobial Stabilizers Made with Zemea® Propanediol
5. Microbes Market and Microbial Products Reviewed in New Research Report at ReportsnReports.com
6. Emergent and DiFusion Form Strategic Partnership to Take CleanFuze™ Antimicrobial Implants to Market
7. PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System
8. PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing
9. Antimicrobial Test Laboratories Emerges as Leading Provider of Virus Testing Services
10. Goats milk with antimicrobial lysozyme speeds recovery from diarrhea
11. Plastics Color Corp. Announces Custom-Blended Antimicrobials for Polymers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):